| Line Item | 2025-10-31 | Y/Y |
|---|---|---|
| Revenue | $26.6M | +30.7% |
| Cost of Revenue | $8.9M | +44.9% |
| Gross Profit | $17.7M | +24.6% |
| R&D Expense | $2.4M | +9.2% |
| SG&A Expense | $10.7M | +27.9% |
| Operating Income | $4.5M | +26.6% |
| Pre-tax Income | $5.5M | +19.5% |
| Income Tax | $1.4M | +43.2% |
| Net Income | $4.1M |
| Line Item | 2025-10-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $28.7M | +27.6% |
| Accounts Receivable | $3.7M | +6.9% |
| Inventory | $13.6M | -2.4% |
| Current Assets | $50.0M | +16.3% |
| Total Assets | $64.5M | +12.1% |
| Current Liabilities | $5.6M | +44.8% |
| Total Liabilities | $6.4M | +44.4% |
| Line Item | 2025-10-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $7.2M | +194.1% |
| Capital Expenditures | $1.2M | +133.0% |
| Investing Cash Flow | -$1.2M | +72.9% |
| Financing Cash Flow | -$16K | +0.0% |
| Free Cash Flow | $6.0M | +209.9% |
| +13.3% |
| EPS (Basic) | $0.37 | +12.1% |
| EPS (Diluted) | $0.37 | +15.6% |
| Stockholders' Equity |
| $58.1M |
| +9.4% |